Health state utility values in patients undergoing endoscopic sinus surgery

Laryngoscope

Volumn 121, Issue 12, 2011, Pages 2672-2678

  Soler, Zachary M ^a   Wittenberg, Eve ^b   Schlosser, Rodney J ^a   MacE, Jess C ^c   Smith, Timothy L ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b BRANDEIS UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

cost benefit analysis; endoscopic surgical procedure; Sinusitis; treatment utility

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC RHINITIS; CHRONIC SINUSITIS; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; ENDOSCOPIC SINUS SURGERY; ENDOSCOPY; FEMALE; HEALTH CARE COST; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RHINOSINUSITIS; SCORING SYSTEM; SHORT FORM 36;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; COHORT STUDIES; CONFIDENCE INTERVALS; ENDOSCOPY; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PARANASAL SINUS DISEASES; PATIENT SELECTION; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RHINITIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SINUSITIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 82155175659     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.21847     Document Type: Article

References (36)

1. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 2004; 131: S1-S62. (Pubitemid 39577605)
2. Soler ZM, Smith TL,. Quality of life outcomes after functional endoscopic sinus surgery. Otolaryngol Clin North Am 2010; 43: 605-612.
3. Torrance GW,. Measurement of health state utilities for economic appraisal: A review. J Health Econ 1986; 5: 1-30. (Pubitemid 16098443)
4. Ware JE, Kosinski M, Gandek BG, et al. The factor structure of the SF-36® health survey in 10 countries: Results from the International Quality of Life Assessment (IQOLA) project. J Clin Epidemiol 1998; 51: 1159-1165. (Pubitemid 28527171)
5. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC,. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996; 276: 1172-1177. (Pubitemid 26329746)
6. Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline. Otolaryngol Head Neck Surg 2007; 137 (Suppl): S1-S31.
7. Lund VJ, Mackay IS,. Staging in rhinosinusitis. Rhinology 1993; 31: 183-184.
8. Lund VJ, Kennedy DW,. Staging for rhinosinusitis. Otolaryngol Head Neck Surg 1997; 117: S35-S40. (Pubitemid 27435427)
9. TM Administration Manual. 3rd ed. Haddon Heights, NJ: Sensonics; 1995: 1-17.
10. Benninger MS, Senior BA,. The development of the rhinosinusitis disability index. Arch Otolaryngol Head Neck Surg 1997; 123: 1175-1179. (Pubitemid 27481580)
11. Brazier J, Roberts J, Deverill M,. The estimation of preference-based measures of health from the SF-36. J Health Econ 2002; 21: 271-292. (Pubitemid 34143147)
12. Brazier J, Roberts J, Tsuchiya A, Busschbach J,. A comparison of the EQ-5D and SF-6D across 7 patient groups. Health Econ 2004; 13: 873-884. (Pubitemid 39264234)
13. Walters SJ, Brazier J,. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes 2003; 1: 4.
14. Soler ZM, Smith TL,. Quality-of-life outcomes after endoscopic sinus surgery: How long is long enough? Otolaryngol Head Neck Surg 2010; 143: 621-625.
15. Hanmer J, Lawrence WF, Anderson JP, Kaplan RM, Fryback DG,. Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Med Decis Making 2006; 26: 391-400. (Pubitemid 44050843)
16. Hunink M, Glaziou P, Siegel J, et al. Decision Making in Health and Medicine: Integrating Evidence and Values. New York, NY: Cambridge University Press; 2001.
17. Bhattacharyya N,. Ambulatory sinus and nasal surgery in the United States: demographics and perioperative outcomes. Laryngoscope 2010; 120: 635-638.
18. Saha S, Hoerger TJ, Pignone MP, Teutsch SM, Helfand M, Mandelblatt JS,. The art and science of incorporating cost-effectiveness into evidence-based recommendations for clinical preventative services. Am J Prev Med 2001; 20: 36-43. (Pubitemid 33732965)
19. Otto RA, Dobie RA, Lawrence V, Sakai C,. Impact of laryngectomy on quality of life: Perspective of the patient versus that of the health care provider. Ann Otol Rhinol Laryngol 1997; 106: 693-699. (Pubitemid 27353506)
20. Ubel PA, Loewenstein G, Schwarz N, Smith D,. Misimagining the unimaginable: The disability paradox and health care decision making. Health Psychol 2005; 24: S57-S62. (Pubitemid 41099126)
21. Feeny D, Wu L, Eng K,. Comparing Short Form 6D, standard gamble, and Health Utilities Index Mark 2 and Mark 3 utility scores: results from total hip arthroplasty patients. Qual Life Res 2004; 13: 1659-1670. (Pubitemid 41215246)
22. Longworth L, Bryan S,. An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ 2003; 12: 1061-1067. (Pubitemid 38035310)
23. Kontodimopoulos N, Niakas D,. An estimate of lifelong costs and QALYs in renal replacement therapy based on patients' life expectancy. Health Policy 2008; 86: 85-96. (Pubitemid 351296306)
24. Szende A, Leidy NK, Stahl E, Svensson K,. Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D. Qual Life Res 2009; 18: 267-272.
25. Vossius C, Nilsen OB, Larsen JP,. Health state values during the first year of drug treatment in early-stage Parkinson's disease: a prospective, population-based, cohort study. Drugs Aging 2009; 26: 973-980.
26. Hatoum HT, Brazier JE, Akhras KS,. Comparison of the HUI3 with the SF-36 preference based SF-6D in a clinical trial setting. Value Health 2004; 7: 602-609. (Pubitemid 39390840)
27. Kontodimopoulos N, Argiriou M, Theakos N, Niakas D,. The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure. Eur J Health Econ. In press.
28. Garster NC, Palta M, Sweitzer NK, Kaplan RM, Fryback DG,. Measuring health-related quality of life in population-based studies of coronary heart disease: comparing six generic indexes and a disease-specific proxy score. Qual Life Res 2009; 18: 1239-1247.
29. Joore M, Brunenberg D, Nelemans P, et al. The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility rations: results across five trial-based cost-utility studies. Value Health 2010; 13: 222-229.
30. Barton GR, Bankart J, Davis AC,. A comparison of the quality of life of hearing-impaired people as estimated by three different utility measures. Int J Audiol 2005; 44: 157-163. (Pubitemid 40694911)
31. Barton GR, Bankart J, Davis AC, Summerfield QA,. Comparing utility scores before and after hearing-aid provision: results according to the EQ-5D, HUI3 and SF-6D. Appl Health Econ Health Policy 2004; 3: 103-105. (Pubitemid 41018308)
32. Schmidlin M, Fritsch K, Mathews F, Thurnheer R, Senn O, Bloch KE,. Utility indices in patients with the obstructive sleep apnea syndrome. Respiration 2010; 79: 200-208.
33. Saad AA, Ashcroft DM, Watson KD, Symmons DP, Noyce PR, Hyrich KL,. Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies. Arthritis Care Res 2010; 62: 345-353.
34. Slobegean GP, Younger A, Apostle KL, et al. Preference-based quality of life of end-stage ankle arthritis treated with arthroplasty or arthrodesis. Foot Ankle Int 2010; 31: 563-566.
35. Osnes-Ringen H, Kvamme MK, Kristiansen IS, et al. Cost-effectiveness analyses of elective orthopaedic surgical procedures in patients with inflammatory arthropathies. Scand J Rheumatol 2011; 40: 108-115.
36. Sauerland S, Weiner S, Dolezolova K, et al. Mapping utility scores from a disease-specific quality of life measure in bariatric surgery patients. Value Health 2009: 12: 364-370.